2015
DOI: 10.1007/s00430-015-0445-7
|View full text |Cite
|
Sign up to set email alerts
|

Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase

Abstract: Zika virus is an emerging mosquito-borne flavivirus currently causing large epidemics in the Pacific Ocean region and Brazil. Clinically, Zika fever resembles dengue fever, but is less severe. Whereas the clinical syndrome and laboratory diagnostic procedures have been described, little attention was paid to the immunology of the disease and its possible use for clinical follow-up of patients. Here, we investigate the role of cytokines in the pathogenesis of Zika fever in travelers returning from Asia, the Pac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

18
134
1
4

Year Published

2016
2016
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 139 publications
(157 citation statements)
references
References 18 publications
18
134
1
4
Order By: Relevance
“…Early in the Ebola epidemic, several patients received a combination of ZMapp antibody and the anti-viral Favipiravir, which led to recovery [78,79]. Reports of enhanced production of proinflammatory cytokines/ chemokines [57,58,80], which are associated with Zika pathogenicity, suggest that anti-inflammatory treatments could ameliorate disease outcomes. We hypothesize that a good candidate for combinational treatment would be one of the immunomodulatory therapeutics, such as AAL-R, that has undergone FDA approval.…”
Section: Combinational Therapymentioning
confidence: 99%
“…Early in the Ebola epidemic, several patients received a combination of ZMapp antibody and the anti-viral Favipiravir, which led to recovery [78,79]. Reports of enhanced production of proinflammatory cytokines/ chemokines [57,58,80], which are associated with Zika pathogenicity, suggest that anti-inflammatory treatments could ameliorate disease outcomes. We hypothesize that a good candidate for combinational treatment would be one of the immunomodulatory therapeutics, such as AAL-R, that has undergone FDA approval.…”
Section: Combinational Therapymentioning
confidence: 99%
“…Human skin fibrobasts, epidermal keratinocytes and immature dendritic cells were found to permit entry of ZKV [42] . ZKV-infectioninduced formation of autophagosomes, expression of antiviral antigen clusters (RIG-1, MDA-5 and TLR3) and activation of T cells (Th1, Th2, Th9 and Th17) [43] .…”
Section: Recent Developments Zika Virus (Zkv) and Zika Virus Vaccine mentioning
confidence: 99%
“…Sitokin düzeylerindeki artışların ilerleyen dönemlerde de devam ettiği gözlen-miştir. İyileşme döneminde sağlıklı kontrollerle karşılaştırıldığında granülosit-makrofaj koloni stimülan faktör (GM-CSF) ve fibroblast büyüme faktörü (FGF) düzeylerinde anlamlı artışlar olduğu gösterilmiştir (73) .…”
Section: Patogenezunclassified